FINWIRES · TerminalLIVE
FINWIRES

New Zealand Consumer Confidence Nears Three-Year Low as Oil Shock Weighs, Says ANZ Research

作者

-- Consumer confidence in New Zealand fell to its lowest read in roughly three years in April, as a looming oil shock raised concerns about the broader economic outlook and downside risk for retailers, ANZ Research said Friday.

The ANZ-Roy Morgan Consumer Confidence Index declined 11 points to 80.3 in April from 91.3 in March. The index has also dropped 20 points over the past two months since the Middle East conflict began and pushed up global fuel prices.

Expectations for inflation rose by about another full percentage point to 6.6%. The net proportion of households considering it "a good time to buy a major household item" slid 11 points to negative 25, the lowest since September 2024.

The firm said it is too soon for the oil shock to have had a meaningful impact on household incomes, and that the decline instead reflects rising cost of living, with a growing wariness among retailers about the future activity levels.

However, consumer confidence, now at levels seen in 2022 and 2023, is "clearly hurting" as higher petrol prices dent weekly budgets.

While consumer inflation expectations are not the central bank's main focus, as they don't directly influence price setting, the gap between consumer inflation expectations of 6.6% and firms' wage expectations of 2.5% is widening, it added.

相關文章

Asia

Telix公司稱,其膠質瘤成像候選藥物的上市許可申請已獲歐洲審查委員會受理;股價上漲3%。

Telix Pharmaceuticals(ASX:TLX)週五宣布,其膠質瘤成像候選藥物TLX101-Px在歐洲提交的上市許可申請已獲驗證並被受理,進入為期210天的積極評估階段。 該公司在聲明中表示,正在尋求符合當前臨床實踐指南的廣泛臨床適應症,預計在第210天取得積極結果後,將很快獲得各國的上市許可。 該公司表示,其目標是擴大患者獲得先進影像技術的機會,該技術能夠區分成人和兒童的進展性或復發性膠質瘤與治療相關變化,並有可能在未來開發出其他適應症。 聲明也指出,TLX101-Px同時也被開發為Telix膠質母細胞瘤治療候選藥物TLX101-Tx的病患選擇和療效評估工具。 TLX101-Tx已在歐洲和美國取得孤兒藥資格認定。 該公司表示,TLX101-Tx治療復發性膠質母細胞瘤患者的III期IPAX-BrIGHT試驗已在全球範圍內啟動患者給藥,並將在多個歐洲國家進行。 Telix Pharmaceuticals的股價在上週五的交易中上漲了3%。

$ASX:TLX
Asia

Zozo公司2025財年獲利成長6%

Zozo(東京證券交易所代號:3092)2025財年歸屬於母公司股東的淨利年增5.7%,達479.3億日圓,高於上年的453.5億日圓。 根據週四提交給東京證券交易所的文件,這家購物中心營運商的基本每股收益從去年的50.90日圓增至54.11日圓。 截至3月31日的整個財年,淨銷售額年增7.2%,達到2,283.7億日圓,高於上年的2,131.3億日圓。 該公司宣布派發年終股息,每股0.20日元,將於6月11日起支付。 該公司預計2026財年歸屬於股東的淨利為497億日元,每股收益為56.20日元,淨銷售額為2,419億日元。 Zozo計劃在本年度派發每股20日圓的期中股息和年終股息,高於去年同期的金額。

$TYO:3092
Asia

EML Payments表示,監管機構延長了所需擔保結構的實施日期。

EML Payments(ASX:EML)週五向澳洲證券交易所提交的文件顯示,澳洲審慎監理局(APRA)和澳洲儲備銀行(RBA)已同意延長所需授權存款機構擔保結構的實施日期,前提是EML Payment Solutions透過定期報告證明其在獲得擔保方面取得了「令人滿意的進展」。 EML Payment Solutions正與多家國內外金融機構、法律顧問和受託服務提供者合作,共同設計所需的擔保結構。 監管機構先前曾表示,他們要求該公司在周四之前就其某些EML Payment Solutions專案的儲值負債獲得授權存款機構的擔保。

$ASX:EML